Free Newsletter
Scientists plot first moves for Project Checkmate
A collaboration between the Scripps Research Institute and IBM to find new antidotes to flu before new mutations surface is making some initial progress. Dubbed Project Checkmate, scientists are using phage displays to identify antibodies that can be used to fight influenza. The project hopes to employ supercomputers to anticipate the way that the flu mutates and moves. Researchers could develop new drugs for new versions of the flu that had yet to surface in the public. Scientists are waiting to hear back on their grant application to the NIH.
- read the article from the Palm Beach Post
Related Articles:
IBM gains $1.4B IT pact with AstraZeneca. Report
IBM to put worker genetic data off limits. Report
Indonesia opens up access to bird flu gene codes. Report
IBM introduces grid medical storage upgrade. Report
More stories about Avian flu Scripps Research Institute National Institutes of Health influenza antibodies
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: